INS and Hyperglycemia: All the subjects in this study were undergoing medication for hyperglycemia ranging from oral hypoglycaemic agents (OHA) (n=79; 66.4%), insulin (n=8; 6.7%), and OHA with insulin (n=32; 26.8%) (Figure 2).